SEARCH RESULTS FOR

Opthea Announces Decision to Discontinue Wet AMD Trials

Opthea Announces COAST Phase 3 Trial Topline Results

Opthea Announces Phase 2b Wet AMD Publication

Opthea Reports Half Year Results and Business Updates

Opthea Completes Drug Product PPQ Campaign

Opthea Completes COAST Final Week 52 Patient Visit

Sr. Director, Regulatory Affairs

Opthea to Present at Oppenheimer Healthcare Conference

Opthea Wet AMD Data Featured at Macula Society Meeting

Opthea to Host Investor Days in New York and Australia